Design and Efficacy of an Ultrashort Antimicrobial Peptide-levofloxacinConjugate Against Resistant Bacteria: A Novel Approach to CombatAntimicrobial Resistance
UP5-C-Levo is a promising therapeutic candidate for the treatment of MDR and biofilm-associated infections. Its strong antibacterial and antibiofilm activity, combined with a favorable safety profile, supports further preclinical development and potential clinical translation.
Authors
- Nizar Mhaidat
- Ammar Almaaytah
- Salsabeel H. Sabi
- Aseel Rashdan
Institutions
- University of Jordan (JO)
- Jordan University of Science and Technology (JO)
- Hashemite University (JO)
Publication Details
- Journal
- Current Pharmaceutical Biotechnology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.2174/0113892010392077251119101656
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00